[1] 胡利娟, 黄晓军. 慢性髓细胞性白血病靶向治疗现状和挑战[J]. 中华内科杂志, 2022, 61(12): 1285-1290. [2] 张小帅, 刘兵城, 杜新, 等. 初诊慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗现状分析: 国内多中心、回顾性真实世界研究[J]. 中华血液学杂志, 2024, 45(3): 215-224. [3] ZHENG X H, WU Y Q, BI J C, et al. The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy[J]. Cell Mol Immunol, 2022, 19(2): 192-209. [4] RAMACHANDRA N, GUPTA M, SCHWARTZ L, et al. Role of IL8 in myeloid malignancies[J]. Leuk Lymphoma, 2023, 64(11): 1742-1751. [5] LEWIS B P, BURGE C B, BARTEL D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120(1): 15-20. [6] DONG X Y, FANG Z G, YU M X, et al. Knockdown of long noncoding RNA HOXA-AS2 suppresses chemoresistance of acute myeloid leukemia via the miR-520c-3p/S100A4 axis[J]. Cell Physiol Biochem, 2018, 51(2): 886-896. [7] GULHANE P, NIMSARKAR P, KHARAT K, et al. Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach[J]. Oncotarget, 2022, 13: 725-746. [8] CHEN J L, PING Y H, TSENG M J, et al. Notch1-promoted TRPA1 expression in erythroleukemic cells suppresses erythroid but enhances megakaryocyte differentiation[J]. Sci Rep, 2017, 7: 42883. [9] 陆贵伟, 吴华. CXCL8及其受体在肿瘤细胞中的作用研究进展[J]. 中外医学研究, 2023, 21(26): 177-181. [10] LI Z P, SUN M Z, LV X X, et al. ETV6 regulates hemin-induced erythroid differentiation of K562 cells through mediating the raf/MEK/ERK pathway[J]. Biol Pharm Bull, 2022, 45(3): 250-259. [11] 温东晟, 朱思濛, 邱煜程, 等. 炎症反应的负性调控机制[J]. 生命的化学, 2019, 39(6): 1194-1198. [12] WANG D S, SI S, WANG Q, et al. MiR-27a promotes hemin-induced erythroid differentiation of K562 cells by targeting CDC25B[J]. Cell Physiol Biochem, 2018, 46(1): 365-374. [13] CHOONG M L, YANG H H, MCNIECE I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis[J]. Exp Hematol, 2007, 35(4): 551-564. [14] PEREKHRESTENKO T, DIACHENKO M, SVIEZHENTSEVA I, et al. Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors[J]. Georgian Med News, 2015(240): 43-50. [15] 许晓炜, 李彦卿, 刘江. 粒系集落刺激因子联合促红细胞生成素治疗慢粒白血病伴贫血的疗效及对营养状况的影响[J]. 中国食物与营养, 2021, 27(7): 73-76. [16] 祝远彬, 王营营, 邢士刚, 等. MiR-520c-3p靶向MEX3A调控肺癌细胞增殖、凋亡的分子机制[J]. 现代免疫学, 2020, 40(4): 281-288. [17] 赵英旋, 白玉勤, 欧阳卫东. 结直肠癌干细胞中miR-520c-3p的表达及其对丙酮酸代谢的调控机制研究[J]. 中国普通外科杂志, 2023, 32(10): 1531-1538. [18] KANEKO K, OHBA K, HIROSE T, et al. Expression of (pro) renin receptor during rapamycin-induced erythropoiesis in K562 erythroleukemia cells and its possible dual actions on erythropoiesis[J]. Tohoku J Exp Med, 2017, 241(1): 35-43. |